Managing Hormones and Acne During Perimenopause

Introduction to Perimenopausal Acne

• The American Academy of Dermatology recommends a combination approach using topical treatments with hormonal therapy for perimenopausal women with acne, as it is the most effective strategy for balancing hormones and controlling acne 1, 2
• Androgens like testosterone and dehydroepiandrosterone sulfate (DHEA-S) play central roles in acne pathogenesis during the perimenopausal period 2

First-Line Treatment Approach

• The American Academy of Dermatology strongly recommends beginning with multimodal topical therapy combining multiple mechanisms of action 1
• Benzoyl peroxide is strongly recommended as a cornerstone treatment for its antimicrobial properties and ability to prevent bacterial resistance 1, 3
• Topical retinoids are strongly recommended for normalizing follicular keratinization 1, 2
• Fixed-dose combination products provide superior efficacy 1
• Topical antibiotics should never be used as monotherapy due to bacterial resistance risk 1, 3

Hormonal Therapy Options

• Spironolactone is the first-choice oral anti-androgen therapy for perimenopausal women with acne, with a starting dose of 50-100 mg daily 2
• Potassium monitoring is of low usefulness in patients without risk factors for hyperkalemia 1
• Combined oral contraceptives with FDA approval for acne include ethinyl estradiol/norgestimate, ethinyl estradiol/norethindrone acetate/ferrous fumarate, ethinyl estradiol/drospirenone, and ethinyl estradiol/drospirenone/levomefolate 2, 4

Treatment Algorithm Based on Acne Severity

• For mild acne, topical therapy with benzoyl peroxide and topical retinoid is recommended 1, 3
• For moderate to severe acne, combination topical therapy and spironolactone are recommended 1
• For severe, scarring, or treatment-resistant acne, consider isotretinoin with careful monitoring of liver function tests and lipids 1, 5

Laboratory Evaluation

• Baseline testing is recommended for women with moderate to severe acne or signs of hyperandrogenism, including total and free testosterone and DHEA-S 1, 2
• Patients with abnormal endocrine testing should be evaluated by an endocrinologist 1

Common Pitfalls to Avoid

• Using topical antibiotics as monotherapy increases the risk of bacterial resistance 1, 3
• Failing to consider underlying endocrine disorders that may manifest or worsen during perimenopause 1
• Prescribing COCs to perimenopausal women with cardiovascular risk factors 4